Oncology Drug Market Size, Share, Analysis, Trends, Growth, Forecasts 2032

• Chapter 1 Preface
  • 1.1 Report Description
  • 1.1 Report Scope
• Chapter 2 Research Methodology
  • 2.1 Research Methodology
  • 2.2 Secondary Research
  • 2.3 Primary Research
  • 2.4 Models
    • 2.4.1 Company Share Analysis Model
    • 2.4.2 Revenue Based Modelling
  • 2.5 Research Limitations
• Chapter 3 Executive Summary
  • 3.1 Global Onculogy Drug Market, 2016 – 2026 (USD Million)
  • 3.2 Global Onculogy Drug Market: Snapshot
• Chapter 4 Onculogy Drug Market – Industry Analysis
  • 4.1 Introduction
  • 4.2 Market Drivers
    • 4.2.1 Driving Factor 1 Analysis
    • 4.2.2 Driving Factor 2 Analysis:
  • 4.3 Market Restraints
    • 4.3.1 Restraining Factor Analysis
  • 4.4 Market Opportunities
    • 4.4.1 Market Opportunity & Use-case Analysis
    • 4.4.2 Use – Cases for Onculogy Drug
  • 4.5 Porter’s Five Forces Analysis
  • 4.6 COVID 19 Impact Analysis
    • 4.6.1.1 Impact on Product Development and Technology Adoption
    • 4.6.1.2 Gap Analysis
• Chapter 5 Investment Proposition Analysis
  • 5.1 Global Onculogy Drug Market Attractiveness, By Therapeutic Models
  • 5.2 Global Onculogy Drug Market Attractiveness, By Cancer Type
  • 5.3 Global Onculogy Drug Market Attractiveness, By Region
• Chapter 6 Competitive Landscape
  • 6.1 Company Market Share Analysis - 2019
    • 6.1.1 Global Onculogy Drug Market: Company Market Share, 2019
  • 6.2 Strategic Developments
  • 7.1 Global Onculogy Drug Market Overview: By Therapeutic Models
    • 7.1.1 Global Onculogy Drug Market Revenue Share, By Therapeutic Models, 2019 & 2026
  • 7.2 Global Onculogy Drug Market Analysis/Overview – By Therapeutic Models
    • 7.2.1 Chemotherapy – Overview/Analysis
    • 7.2.2 Targeted Therapy – Overview/Analysis
    • 7.2.3 Immunotherapy – Overview/Analysis
    • 7.2.4 Hormonal Therapy – Overview/Analysis
    • 7.2.5 Others – Overview/Analysis
  • 7.3 Chemotherapy
    • 7.3.1 Global Onculogy Drug Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
  • 7.4 Targeted Therapy
    • 7.4.1 Global Onculogy Drug Market for Targeted Therapy, Revenue (USD Million) 2016 - 2026
  • 7.5 Immunotherapy
    • 7.5.1 Global Onculogy Drug Market for Immunotherapy, Revenue (USD Million) 2016 - 2026
  • 7.6 Hormonal Therapy
    • 7.6.1 Global Onculogy Drug Market for Hormonal Therapy, Revenue (USD Million) 2016 - 2026
  • 7.7 Others
    • 7.7.1 Global Onculogy Drug Market for Others, Revenue (USD Million) 2016 - 2026
  • 8.1 Global Onculogy Drug Market Overview: By Cancer Type
    • 8.1.1 Global Onculogy Drug Market Revenue Share, By Cancer Type, 2019 & 2026
  • 8.2 Global Onculogy Drug Market Analysis/Overview – By Cancer Type
    • 8.2.1 Breast Cancer – Overview/Analysis
    • 8.2.2 Blood Cancer – Overview/Analysis
    • 8.2.3 Prostate Cancer – Overview/Analysis
    • 8.2.4 Skin Cancer – Overview/Analysis
    • 8.2.5 Lung Cancer – Overview/Analysis
    • 8.2.6 Others – Overview/Analysis
  • 8.3 Breast Cancer
    • 8.3.1 Global Onculogy Drug Market for Breast Cancer, Revenue (USD Million) 2016 - 2026
  • 8.4 Blood Cancer
    • 8.4.1 Global Onculogy Drug Market for Blood Cancer, Revenue (USD Million) 2016 - 2026
  • 8.5 Prostate Cancer
    • 8.5.1 Global Onculogy Drug Market for Prostate Cancer, Revenue (USD Million) 2016 - 2026
  • 8.6 Skin Cancer
    • 8.6.1 Global Onculogy Drug Market for Skin Cancer, Revenue (USD Million) 2016 - 2026
  • 8.7 Lung Cancer
    • 8.7.1 Global Onculogy Drug Market for Lung Cancer, Revenue (USD Million) 2016 - 2026
  • 8.8 Others
    • 8.8.1 Global Onculogy Drug Market for Others, Revenue (USD Million) 2016 - 2026
• Chapter 9 Onculogy Drug Market – Regional Analysis
  • 9.1 Global Onculogy Drug Market: Regional Overview
    • 9.1.1 Global Onculogy Drug Market Revenue Share, by Region, 2019 & 2026
    • 9.1.2 Global Onculogy Drug Market Revenue, by Region, 2016 – 2026 (USD Million)
  • 9.2 North America
    • 9.2.1 North America Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
    • 9.2.2 North America Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 9.2.3 North America Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
    • 9.2.4 North America Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
    • 9.2.5 U.S.
    • 9.2.6 Canada
  • 9.3 Europe
    • 9.3.1 Europe Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
    • 9.3.2 Europe Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 9.3.3 Europe Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
    • 9.3.4 Europe Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
    • 9.3.5 Germany
    • 9.3.6 France
    • 9.3.7 U.K.
    • 9.3.8 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
    • 9.4.2 Asia Pacific Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 9.4.3 Asia Pacific Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
    • 9.4.4 Asia Pacific Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
    • 9.4.5 China
    • 9.4.6 Japan
    • 9.4.7 India
    • 9.4.8 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Latin America Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
    • 9.5.2 Latin America Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 9.5.3 Latin America Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
    • 9.5.4 Latin America Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
    • 9.5.5 Brazil
    • 9.5.6 Rest of Latin America
  • 9.6 The Middle-East and Africa
    • 9.6.1 The Middle-East and Africa Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
    • 9.6.2 The Middle-East and Africa Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 9.6.3 The Middle-East and Africa Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
    • 9.6.4 The Middle-East and Africa Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
    • 9.6.5 GCC Countries
    • 9.6.6 Rest of Middle-East Africa
• Chapter 10 Company Profiles
  • 10.1 Johnson & Johnson
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Product Portfolio
    • 10.1.4 Business Strategy
    • 10.1.5 Recent Developments
  • 10.2 Amgen Inc.
  • 10.3 Eli Lilly Co.
  • 10.4 GSK
  • 10.5 Roche Diagnostics
  • 10.6 Merck & Co.
  • 10.7 Pfizer
  • 10.8 Sanofi
  • 10.9 Novartis AG
  • 10.10 Celgene Corporation

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Oncology Drug Market
FIG. 6 Global Oncology Drug Market Attractiveness, By Therapeutic Models
FIG. 7 Global Oncology Drug Market Attractiveness, By Cancer Type
FIG. 8 Global Oncology Drug Market Attractiveness, By End-User
FIG. 9 Company Share Analysis, 2019
FIG. 10 Global Oncology Drug Market Revenue Share, By Therapeutic Models, 2019 & 2026
FIG. 11 Global Oncology Drug Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
FIG. 12 Global Oncology Drug Market for Targeted Therapy, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Oncology Drug Market for Immunotherapy, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Oncology Drug Market for Hormonal Therapy, Revenue (USD Million) 2016 - 2026
FIG. 15 Global Oncology Drug Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 16 Global Oncology Drug Market Revenue Share, By Cancer Type, 2019 & 2026
FIG. 17 Global Oncology Drug Market for Breast Cancer, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Oncology Drug Market for Blood Cancer, Revenue (USD Million) 2016 - 2026
FIG. 19 Global Oncology Drug Market for Prostate Cancer, Revenue (USD Million) 2016 - 2026
FIG. 20 Global Oncology Drug Market for Skin Cancer, Revenue (USD Million) 2016 - 2026
FIG. 21 Global Oncology Drug Market for Lung Cancer, Revenue (USD Million) 2016 - 2026
FIG. 22 Global Oncology Drug Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 23 Global Oncology Drug Market Revenue Share, by Region, 2019 & 2026
FIG. 24 North America Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 25 Europe Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 26 Asia Pacific Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 27 Latin America Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 28 The Middle-East and Africa Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 29 Johnson & Johnson Business Segment Revenue Share, 2018 (%)
FIG. 30 Johnson & Johnson Geographical Segment Revenue Share, 2018 (%)

Table Of Tables

List of Tables

TABLE 1 Global Oncology Drug Market: Snapshot
TABLE 2 Drivers of the Oncology Drug Market: Impact Analysis
TABLE 3 Restraints for the Oncology Drug Market: Impact Analysis
TABLE 4 Global Oncology Drug Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 7 North America Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 8 Europe Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 9 Europe Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 10 Europe Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 11 Asia Pacific Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 12 Asia Pacific Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 13 Asia Pacific Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 14 Latin America Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 15 Latin America Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 16 Latin America Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 17 The Middle-East and Africa Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 18 The Middle-East and Africa Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 19 The Middle-East and Africa Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)